The Mt. Sinai study could open the door to future therapies for Alzheimer’s, amyotrophic lateral sclerosis, brain cancer, and drug addiction.

Blood–brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system. Nature Materials , 2025; DOI: 10.1038/s41563-024-02114-5 Cite This Page : ...

A new lipid nanoparticle system can deliver messenger RNA (mRNA) to the brain via intravenous injection. The findings pave the way for future treatments for conditions like Alzheimer's disease and ...

New York, NY [February 17, 2025]—Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via ...

MILAN (Reuters) -Stellantis announced management changes on Monday as part of a shake-up at the world's fourth-largest automaker launched after the shock exit CEO Carlos Tavares in December.

Australia has provided Papua New Guinea with a $570 million loan, bringing total budget support to over $3.1 billion since 2020. As part of the deal, PNG has agreed to tighten foreign investment ...

Now, scientists have uncovered new structures of transthyretin. The tiny protein known as transthyretin can cause big problems in the body when it misfolds after secretion. While healthy ...

The recent success of the mRNA-LNP vaccines fueled biopharma to explore lipid-based nanoparticles for advanced drug delivery. The industry is now poised to exploit the full therapeutic potential ...

Studies show that this method, which delivers rapid, high-voltage pulsed electrical fields to the tissue, reduces procedure times and risk to adjacent structures. Semaglutide for treating heart ...